NCT05050006: An ongoing trial by Instil Bio
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 month ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05050006 |
|---|---|
| Title | A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes (TILs) in Subjects With Advanced Melanoma (DELTA-1) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 7, 2021 |
| Completion date | Feb. 27, 2023 |
| Required reporting date | Feb. 27, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |